4.5 Article

Pulmonary aspergillosis: diagnosis and treatment

Related references

Note: Only part of the references are listed.
Article Immunology

High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies

Jonathan Tschopp et al.

Summary: Immunoglobulins and therapeutic antibody preparations are linked to a high rate of false-positive BDG tests in hematological patients. The benefits of BDG monitoring need to be balanced against the risk of unnecessary investigations and costs resulting from false-positive tests in this population.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective

Frederic Lamoth et al.

Summary: The treatment of invasive fungal infections remains challenging due to the limitations of current antifungal agents and the emergence of resistant fungal pathogens. There is an urgent need to expand the arsenal of antifungal drugs. Several new drugs are being clinically assessed and may provide useful additions to current therapies, particularly for infections caused by resistant fungi. However, the treatment of some fungal diseases still poses challenges.

CLINICAL INFECTIOUS DISEASES (2022)

Review Infectious Diseases

Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians

Frederic Lamoth

Summary: This review focuses on COVID-19-associated pulmonary aspergillosis (CAPA) and addresses questions regarding the incidence of IPA, the link between viral infection and fungal superinfection, the significance of Aspergillus recovery in respiratory samples, and the management of such cases.

CURRENT OPINION IN INFECTIOUS DISEASES (2022)

Article Microbiology

Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?

Roya Vahedi-Shahandashti et al.

Summary: This study found that Aspergillus terreus isolates defined as susceptible to amphotericin B (AMB) therapy based on minimum inhibitory concentration (MIC) may comprise tolerant phenotypes, explaining the poor outcomes of AMB treatment.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Immunology

Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

Michele Bartoletti et al.

Summary: The study showed a high incidence of CAPA among critically ill COVID-19 patients, and its occurrence seems to alter the natural course of the disease.

CLINICAL INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Invasive mould disease in fatal COVID-19: a systematic review of autopsies

Brittany E. Kula et al.

Summary: Evaluation of autopsy series of COVID-19 decedents showed that invasive mould disease, including COVID-19-associated pulmonary aspergillosis, is a rare finding, only occurring in 2% of cases.

LANCET MICROBE (2021)

Article Immunology

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC

Barbara D. Alexander et al.

Summary: Clinical imaging plays a crucial role in early detection and diagnosis of invasive fungal diseases (IFD). Volumetric high-resolution computed tomography (CT) is the preferred method for lung imaging, providing valuable diagnostic information. Certain radiologic patterns, such as the halo sign and reversed halo sign, can help differentiate between invasive pulmonary aspergillosis and pulmonary mucormycosis.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults

F. Lamoth et al.

Summary: BDG testing may be useful for diagnosing IF, but its performance and utility vary depending on patient population and pretest likelihood of IF.

CLINICAL INFECTIOUS DISEASES (2021)

Review Infectious Diseases

Aspergillosis: Emerging risk groups in critically ill patients

Stefan Kluge et al.

Summary: Invasive aspergillosis is a significant concern for patients in the intensive care unit, especially in those who use corticosteroids to treat underlying conditions like COPD, sepsis, or severe COVID-19. Other key risk factors include COPD, decompensated cirrhosis, liver failure, and severe viral pneumonia. Early recognition and management are crucial for preventing adverse outcomes in these patients.

MEDICAL MYCOLOGY (2021)

Review Dermatology

The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta-analysis

Ying Zhang et al.

Summary: Compared to normal metabolizers, intermediate and poor metabolizers of CYP2C19 had higher voriconazole trough concentrations, while rapid metabolizers had lower concentrations. Poor metabolizers, especially in Asian populations, had a higher proportion of patients within the target therapeutic range.

MYCOSES (2021)

Article Immunology

Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections

Gregoire Caudron de Coquereaumont et al.

Summary: Invasive mold infections are challenging to diagnose, with a particularly high rate of missed diagnosis among nonhematologic cancer patients.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Hematology

Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa

Romain Guery et al.

Summary: Patients with adult T-Cell leukemia/lymphoma (ATL) have a poor prognosis and are prone to infectious complications, especially in the acute subtype. Treatment options include high doses of zidovudine and interferon alfa or chemotherapy, but the infection rate is high. Invasive fungal infections significantly impact survival rates, particularly in acute subtype patients exposed to drug therapy.

ANNALS OF HEMATOLOGY (2021)

Letter Infectious Diseases

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?

Arnaud Fekkar et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Immunology

Aspergillosis Epidemiology, Diagnosis, and Treatment

Jose Cadena et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2021)

Article Infectious Diseases

High -volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum

P. Vergidis et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Review Pharmacology & Pharmacy

Pharmacokinetics and Pharmacodynamics of Posaconazole

Lu Chen et al.

DRUGS (2020)

Article Microbiology

CPAnet Registry-An International Chronic Pulmonary Aspergillosis Registry

Christian B. Laursen et al.

JOURNAL OF FUNGI (2020)

Review Microbiology

Isavuconazole-Animal Data and Clinical Data

Livio Pagano et al.

JOURNAL OF FUNGI (2020)

Review Microbiology

Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside

Marion Aruanno et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections

Alfred O. Ankrah et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Review Medicine, General & Internal

Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients

Koen de Heer et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)

Article Microbiology

Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials

David Andes et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Infectious Diseases

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann et al.

CLINICAL MICROBIOLOGY AND INFECTION (2018)

Article Critical Care Medicine

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

Alexander F. A. D. Schauwvlieghe et al.

LANCET RESPIRATORY MEDICINE (2018)

Review Infectious Diseases

Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment

Lore Vanderbeke et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2018)

Review Biochemistry & Molecular Biology

Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy

Jarrett R. Amsden et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)

Article Infectious Diseases

Early diagnosis of invasive mould infections and disease

Frederic Lamoth et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

Article Respiratory System

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

David W. Denning et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Review Microbiology

Aspergillus fumigatus-Related Species in Clinical Practice

Frederic Lamoth

FRONTIERS IN MICROBIOLOGY (2016)

Review Microbiology

Allergic Bronchopulmonary Aspergillosis

Michael C. Tracy et al.

JOURNAL OF FUNGI (2016)

Article Medicine, General & Internal

Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial

Kieren A. Marr et al.

ANNALS OF INTERNAL MEDICINE (2015)

Review Pharmacology & Pharmacy

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

Paul E. Verweij et al.

DRUG RESISTANCE UPDATES (2015)

Review Infectious Diseases

Voriconazole-associated phototoxic dermatoses and skin cancer

Rakesh K. Goyal

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)

Review Medicine, General & Internal

Galactomannan detection for invasive aspergillosis in immunocompromised patients

Mariska M. G. Leeflang et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)

Article Immunology

Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

J. W. M. van der Linden et al.

EMERGING INFECTIOUS DISEASES (2015)

Article Medical Laboratory Technology

Nonmolecular Methods for the Diagnosis of Respiratory Fungal Infections

Frederic Lamoth et al.

CLINICS IN LABORATORY MEDICINE (2014)

Article Infectious Diseases

Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis

Beomsu Shin et al.

JOURNAL OF INFECTION (2014)

Review Pharmacology & Pharmacy

Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity

Richard J. Hamill

DRUGS (2013)

Article Cardiac & Cardiovascular Systems

The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis

Yuta Kono et al.

RESPIRATORY MEDICINE (2013)

Article Infectious Diseases

Aspergillus sp isolated in critically ill patients with extracorporeal membrane oxygenation support

Cecile Aubron et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)

Article Critical Care Medicine

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

Stijn I. Blot et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Article Infectious Diseases

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

William J. Steinbach et al.

JOURNAL OF INFECTION (2012)

Article Infectious Diseases

Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis

Koichi Izumikawa et al.

MEDICAL MYCOLOGY (2012)

Article Microbiology

Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens

P. Lewis White et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2011)

Article Hematology

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

Livio Pagano et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)

Article Microbiology

The (1,3)β-D-Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung Transplantation

Barbara D. Alexander et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2010)

Review Infectious Diseases

Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis

Carlo Mengoli et al.

LANCET INFECTIOUS DISEASES (2009)

Article Immunology

Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis

CD Pfeiffer et al.

CLINICAL INFECTIOUS DISEASES (2006)

Review Pharmacology & Pharmacy

Update on antifungal drug resistance mechanisms of Aspergillus fumigatus

G Chamilos et al.

DRUG RESISTANCE UPDATES (2005)

Article Critical Care Medicine

Invasive aspergillosis in critically ill patients without malignancy

W Meersseman et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)

Article Infectious Diseases

Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients

ML Uffredi et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2003)

Article Medicine, General & Internal

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

R Herbrecht et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Microbiology

Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis

WR Kirkpatrick et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)